Haematology
Product Highlights
- Broad coverage of clinically relevant hematologic mutations
- High sensitivity for low-frequency mutation and MRD detection
- Precise, absolute quantification on RainSure dPCR platforms
- Suitable for blood, plasma, and RNA-based assays
- Custom assay development available for additional targets
Product Description
RainSure offers a comprehensive range of digital PCR assays for hematologic malignancies, supporting applications in diagnosis, therapy guidance, and measurable residual disease (MRD) monitoring. Our portfolio includes key mutations across leukemias and lymphoid disorders, designed for high-sensitivity detection and robust quantification. If you require an assay not listed, our team can develop custom solutions tailored to your needs.
Available Assays
BCR-ABL
- p210 Fusion
- T315I Mutation
- W288FS Type A
- W288FS Type B
- W288FS Type D
JAK2
- V617F
NPM1 (RNA-based)
- Type A
- Type B
- Type D
IDH1
- R132C
- R132G
- R132H
TP53
- R175H
- R248L
- R273C
- R273H
MYD88
- L265P
